Net income attributable to shareholders totaled $115 million
IVL’s operating cash flow in the first nine months of 2025 reached $985 million
The company booked €45 million in savings in Q3 as part of a broader €300 million annual cost-reduction target by 2027
Logoplaste is recognised for its expertise in injection molding and blow molding, delivering innovative, high-performance packaging
Godavari Biorefineries’ 200 KLPD fungible grain/maize distillery is targeted for commissioning in Q4 FY26
NuCode optimizes crop yield and health begins with a scientific understanding of biological processes within plants and soil.
This collaboration marks a significant step towards strengthening India's self-reliant water technology ecosystem
EBITDA is by 16% to Rs. 43 crore and total revenue up by 15% to Rs. 492 crore
The two‑day summit will feature 48 sessions, including a plenary, 27 technical discussions and 11 state‑specific forums
Quarter reflects planned shutdowns, safety-led commissioning activity and dual-feed transition across 65 percent of installed capacity
The triple tranche complements the bond maturity profile while reducing overall Group-wide funding costs
The company has posted net profit of Rs. 24.23 crore for the 6 months period ended September 30, 2025
The company delivered a solid performance with Profit After Tax up 12% in Q2 and 10% in H1 YoY
The company could successfully increase capacity utilization of various plants and achieved higher production across major products
The company reported Q2 FY26 PAT higher at Rs. 105 crore
Adjusted EBITDA fell to $94 million, while free cash flow surged to $157 million
The company plans to utilize the proceeds from the IPO to expand its existing formulation plant
The company’s Q2 revenue climbed 10.33 per cent year-on-year to Rs. 539.21 crore
ADNOC and Comera Financial Holdings will create an intelligent, automated platform that directly connects SMEs and suppliers awarded ADNOC contracts to lender support
Net income attributable to Chemours of $60 million, compared with net loss attributable to Chemours of $32 million, in the corresponding prior-year quarter
Subscribe to our newsletter & stay updated.
